Medical Polymer Market Summary
The global medical polymers market size was estimated at USD 19.9 billion in 2022 and is projected to reach USD 36.77 billion by 2030, growing at a CAGR of 8.0% from 2023 to 2030. Factors, such as increasing demand from the medical industry are anticipated to fuel the demand for medical-grade polymers.
Key Market Trends & Insights
- North America was the largest segment in 2022 and accounted for more than 42.0%.
- In terms of product, fibers & resins across the product segment dominated the market in 2022.
- In terms of application, the medical components segment dominated the global medical polymer market in 2022.
Market Size & Forecast
- 2022 Market Size: USD 19.9 Billion
- 2030 Projected Market Size: USD 36.77 Billion
- CAGR (2023-2030): 8.0%
- North America: Largest market in 2022
Polymers are classified as synthetic and natural polymers based on raw materials. Naturally occurring polymers include bio-based polymers, wood, and natural rubber, whereas synthetic polymers include thermosets & thermoplastic resins, elastomers, and fibers. Increasing per capita healthcare spending in the form of health insurance in the U.S. has been one of the significant trends impacting the growth of the market in North America. This is expected to augment the demand for generic drugs and medical devices in the coming years, thereby driving the market in North America during the forecast period. This industry's critical applications include medical components manufacturing and pharmaceutical packaging.
The presence of key government initiatives such as the Affordable Care Act (ACA) and Medicaid has enabled a large percentage of the population to gain access to healthcare facilities and services in the U.S. This has further boosted the demand for branded drugs, medical devices, and healthcare services, thereby driving the need for medical polymers in the country, primarily in applications such as medical components, packaging, and wound care.
The Canadian healthcare industry is attracting significant investments from both the public and private sectors. According to Canadian Institute for Health Information (CIHI), the government planned to spend USD 308 billion in 2021 on the healthcare sector. The country is characterized by high health consciousness and high life expectancy, viz., 85 years for women and 79 years for men, thus, posing lucrative growth opportunities for medical polymer manufacturers in Canada.
Product Insights
Fibers & resins across the product segmentation dominated the market in 2022 in terms of both volume and revenue owing to the high chemical & electrical resistance offered by resins such as polypropylene (PP) and polyethylene (PE). Furthermore, polycarbonate polymer resins offer heat resistance, strength, and toughness, which enables them to replace metal and glass in many medical products. The optical clarity is a vital characteristic in clinical and diagnostic contexts where blood, tissues, and other fluids must be visible.
Extrusion of medical polymers can result in monofilaments, which are single threadlike synthetic fibers. These medical-grade monofilaments can be used in magnetic resonance imaging (MRI) as an alternative to metal filaments. Also, medical polymer fibers exhibit a high strength-to-weight ratio, making them an ideal choice for many minimally invasive devices and medical clothing.
Silicone is a widely used medical elastomer in medical applications. Its favorable characteristics include the ability to operate in temperatures ranging between -50°C and +250°C, water repellency, non-allergic nature, excellent resistance to ozone, weather, and UV rays, and compatibility with steam, ETO, and gamma radiations making it ideal for use in medical applications.
Application Insights
The applications considered for the North America medical polymers industry include medical device packaging, medical components, wound care, mobility aids, and tooth implants. Increasing incidences of lifestyle-related diseases in the region, including diabetes and cardiac arrests, have resulted in increased spending on healthcare by the population. This is expected to boost the demand for medical devices, generic drugs, and healthcare services, thereby positively influencing the global medical polymer market size.
Increased global usage of orthopedic soft goods has led to a surge in demand for propylene and polyether ether ketone (PEEK) polymers. PEEK polymer is chosen as a premium material for developing plastic casts and braces used in medical applications owing to its high strength and resistance to adverse environmental conditions. In addition, the global demand for PEEK polymers is expected to rise owing to the increasing efforts by manufacturers of orthopedic goods for reducing the overall weight of their products by material substitution. Moreover, the global demand for PEEK polymers is projected to be driven by their easy molding abilities leading to superior shaping of orthopedic goods.
Region Insights
North America was the largest segment in 2022 and accounted for more than 42.0% of the overall revenue share.Medical Components led the market in 2021, in terms of both volume and revenue in the region. The rising demand for medical polymers in pharmaceutical packaging applications and the rapid growth of pharmaceutical industries in Mexico and Canada is expected to further fuel the growth. For instance, the repealing of stringent regulations by the Mexican government that restricted the establishment of new manufacturing units has resulted in the establishment of new pharmaceutical manufacturing facilities by major companies such as Takeda and Astellas in Mexico.
An increasing geriatric population and rising occurrence of chronic diseases in the region have augmented the demand for medical devices. This is expected to drive the demand for medical polymers in equipment manufacturing over the forecast period. Increasing government investments in the healthcare sector and the growing home healthcare market are anticipated to drive the demand for medical devices, which, in turn, is expected to positively influence the growth of the market for medical polymers over the forecast period.
Key Companies & Market Share Insights
Major players are continuously working on expanding manufacturing capabilities with the rise in demand from the medical industry.In July 2021, Celanese Corporation has announced the expansion of a drug delivery feasibility lab to its Florence, Kentucky R&D center. The building of a new feasibility lab will advance the development of long-acting controlled-release medication delivery. Rising population, pandemics like the COVID-19 outbreak, better living conditions, and rising disposable income are all driving global medical business growth. Some prominent players in the global medical polymer market include:
BASF SE
NatureWorks LLC
Covestro AG
Celanese Corporation
Eastman Chemical Corporation
Evonik Industries AG
Dow Inc.
Exxon Mobil Corporation
Arkema
Koninklijke DSM NV
Formosa Plastics Corporation
Foryou Medical
KRATON CORPORATION
SABIC
Trinseo S.A.